BRIEF-ProPhase Labs Signs Non-Binding LOI For Proposed Reverse Merger With Advanced Biological Laboratories

Reuters12-19

BRIEF-<a href="https://laohu8.com/S/PRPH">ProPhase Labs</a> Signs Non-Binding LOI For Proposed Reverse Merger With Advanced Biological Laboratories

Dec 19 (Reuters) - Prophase Labs Inc PRPH.O:

PROPHASE LABS SIGNS NON-BINDING LOI FOR PROPOSED REVERSE MERGER WITH ADVANCED BIOLOGICAL LABORATORIES
PROPHASE LABS INC: UNDER DEAL, ABL WOULD BECOME MAJORITY OWNER OF COMBINED ENTITY
PROPHASE LABS INC: PROPOSED DEAL FOR MAY IMPLY AN ENTERPRISE VALUE OF UP TO APPROXIMATELY $30 MILLION
PROPHASE LABS INC: UNDER LOI, MAY DECLARE A SPECIAL CASH DIVIDEND OF UP TO $10 MILLION
PROPHASE LABS: PROPOSED DEAL ENVISIONS THAT ABL SHAREHOLDERS WOULD OWN ABOUT 76% OF COMBINED CO AT CLOSING

Source text: ID:nGNX28zCmJ

Further company coverage: PRPH.O

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2592697081?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-12-19 20:05","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2592697081","market":"nz","top_or_hot":-1,"title":"BRIEF-ProPhase Labs Signs Non-Binding LOI For Proposed Reverse Merger With Advanced Biological Laboratories","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-<a href=\"https://laohu8.com/S/PRPH\">ProPhase Labs</a> Signs Non-Binding LOI For Proposed Reverse Merger With Advanced Biological Laboratories</title></head><body><p><span>Dec 19 (Reuters)</span><span> - </span>Prophase Labs Inc <span>PRPH.O</span>:</p><ul><li><p>PROPHASE LABS SIGNS NON-BINDING LOI FOR PROPOSED REVERSE MERGER WITH ADVANCED BIOLOGICAL LABORATORIES</p></li><li><p>PROPHASE LABS INC: UNDER DEAL, ABL WOULD BECOME MAJORITY OWNER OF COMBINED ENTITY</p></li><li><p>PROPHASE LABS INC: PROPOSED DEAL FOR MAY IMPLY AN ENTERPRISE VALUE OF UP TO APPROXIMATELY $30 MILLION</p></li><li><p>PROPHASE LABS INC: UNDER LOI, MAY DECLARE A SPECIAL CASH DIVIDEND OF UP TO $10 MILLION</p></li><li><p>PROPHASE LABS: PROPOSED DEAL ENVISIONS THAT ABL SHAREHOLDERS WOULD OWN ABOUT 76% OF COMBINED CO AT CLOSING</p></li></ul><p>Source text: <span>ID:nGNX28zCmJ</span></p><p>Further company coverage: <span>PRPH.O</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-ProPhase Labs Signs Non-Binding LOI For Proposed Reverse Merger With Advanced Biological Laboratories</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-ProPhase Labs Signs Non-Binding LOI For Proposed Reverse Merger With Advanced Biological Laboratories\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-12-19 20:05</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-<a href=\"https://laohu8.com/S/PRPH\">ProPhase Labs</a> Signs Non-Binding LOI For Proposed Reverse Merger With Advanced Biological Laboratories</title></head><body><p><span>Dec 19 (Reuters)</span><span> - </span>Prophase Labs Inc <span>PRPH.O</span>:</p><ul><li><p>PROPHASE LABS SIGNS NON-BINDING LOI FOR PROPOSED REVERSE MERGER WITH ADVANCED BIOLOGICAL LABORATORIES</p></li><li><p>PROPHASE LABS INC: UNDER DEAL, ABL WOULD BECOME MAJORITY OWNER OF COMBINED ENTITY</p></li><li><p>PROPHASE LABS INC: PROPOSED DEAL FOR MAY IMPLY AN ENTERPRISE VALUE OF UP TO APPROXIMATELY $30 MILLION</p></li><li><p>PROPHASE LABS INC: UNDER LOI, MAY DECLARE A SPECIAL CASH DIVIDEND OF UP TO $10 MILLION</p></li><li><p>PROPHASE LABS: PROPOSED DEAL ENVISIONS THAT ABL SHAREHOLDERS WOULD OWN ABOUT 76% OF COMBINED CO AT CLOSING</p></li></ul><p>Source text: <span>ID:nGNX28zCmJ</span></p><p>Further company coverage: <span>PRPH.O</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4007","symbol_name":"制药","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251219:nFWN3XP0BM:1","article_id":"2592697081","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2592697081","pubTimestamp":1766145910,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BRIEF-ProPhase Labs Signs Non-Binding LOI For Proposed Reverse Merger With Advanced Biological LaboratoriesDec 19 (Reuters) - Prophase Labs Inc PRPH.O:PROPHASE LABS SIGNS NON-BINDING LOI FOR PROPOSED ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4007":"制药","PRPH":"ProPhase Labs"},"translate_title":"简介-ProPhase Labs签署不具约束力的意向书，拟与Advanced Biological Laboratories进行反向合并","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"PRPH":0.9},"content_text":"BRIEF-ProPhase Labs Signs Non-Binding LOI For Proposed Reverse Merger With Advanced Biological LaboratoriesDec 19 (Reuters) - Prophase Labs Inc PRPH.O:PROPHASE LABS SIGNS NON-BINDING LOI FOR PROPOSED REVERSE MERGER WITH ADVANCED BIOLOGICAL LABORATORIESPROPHASE LABS INC: UNDER DEAL, ABL WOULD BECOME MAJORITY OWNER OF COMBINED ENTITYPROPHASE LABS INC: PROPOSED DEAL FOR MAY IMPLY AN ENTERPRISE VALUE OF UP TO APPROXIMATELY $30 MILLIONPROPHASE LABS INC: UNDER LOI, MAY DECLARE A SPECIAL CASH DIVIDEND OF UP TO $10 MILLIONPROPHASE LABS: PROPOSED DEAL ENVISIONS THAT ABL SHAREHOLDERS WOULD OWN ABOUT 76% OF COMBINED CO AT CLOSINGSource text: ID:nGNX28zCmJFurther company coverage: PRPH.O ((Reuters.Briefs@thomsonreuters.com;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2592697081","isCrawlerRequest":true}